Inhibiting PHGDH or other enzymes in the serine–glycine pathway reduces the availability of one-carbon units required for nucleotide synthesis, impairing DNA repair and increasing the sensitivity of cancer cells to radiotherapy. This evidence concerns the gene PHGDH and cancer.